Clinical Trials Directory

Trials / Unknown

UnknownNCT01942525

Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants

Intrauterine Growth Restriction Has an Impact on Amplitude-integrated EEG in Preterm Infants

Status
Unknown
Phase
Study type
Observational
Enrollment
156 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
23 Weeks – 30 Weeks
Healthy volunteers
Not accepted

Summary

Objective: The impact of intrauterine growth restriction (IUGR) on perinatal morbidity and long-term neurodevelopmental outcome has been published in numerous studies. Throughout this analysis, the influence of IUGR on the postnatal amplitude-integrated EEG (aEEG) in preterm infants below 30 weeks of gestation was assessed. The second concern was the correlation between the pattern of the aEEG in the first two weeks with neurodevelopmental outcome, comparing infants with and without IUGR. Methods: Routinely assessed aEEG data of preterm infants with IUGR born below 30 weeks of gestation in the years 2005 until 2007 were analysed retrospectively according to the aEEG score (combining occurrence of sleep-wake-cycles, background activity and suspected seizure activity). Neurodevelopmental outcome was evaluated at 24 months using the Bayley Scales of Infant Development and standardized neurologic examination.

Conditions

Interventions

TypeNameDescription
OTHERaEEGThe amplitude integrated EEG was performed using a single-channel, biparietal aEEG (CFM 6000; Natus Medical Incorporated, San Carlos, CA)

Timeline

Start date
2010-06-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2013-09-16
Last updated
2013-09-16

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01942525. Inclusion in this directory is not an endorsement.